Source: Eur Respir J 2008; 32: 17-24
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Keene, O. N., Calverley, P. M. A., Jones, P. W., Vestbo, J., Anderson, J. A.. Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J 2008; 32: 17-24

Member's Comments

No comment yet.

Related content which might interest you: Statistical analysis of COPD exacerbations Source: Eur Respir J 2008; 32: 1421-1422 Year: 2008 Statistical cluster analysis on the BTS refractory asthma cohort Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 A multivariate geo-statistical Bayesian model for analyzing the spatial prevalence of COPD: Implications on risk factors Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 LSC Abstract – Multi-level differential network analysis of COPD exacerbations Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Multi-level differential network analysis of COPD exacerbations Source: Eur Respir J, 50 (3) 1700075; 10.1183/13993003.00075-2017 Year: 2017 Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models Source: International Congress 2015 – COPD: interesting notes Year: 2015 Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Hierarchical linear models for longitudinal change in COPD - is there an effect of differential dropout between treatment groups on estimated decline rates? Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001 Elastic principal graphs for clinical trajectory analysis in COPD: a COPDGene study Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 The superexacerbator phenotype in patients with COPD: a descriptive analysis Source: ERJ Open Res, 5 (2) 00235-2018; 10.1183/23120541.00235-2018 Year: 2019 Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis Source: Eur Respir J, 54 (1) 1900364; 10.1183/13993003.00364-2019 Year: 2019 High-dimensional multivariable analysis of asthma and its co-morbidities Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action Year: 2020 Occupational exposure as a predictor of asthma exacerbation – a multicenter multivariate logistical analysis. Source: Virtual Congress 2021 – Occupational rhinitis and asthma Year: 2021 Lung function decline in COPD trials: bias from regression to the mean Source: Eur Respir J 2008; 32: 829-831 Year: 2008 Estimation of the prognostic value of respiratory and metabolic parameters in treatment of shock patients by means of logistic regression analysis Source: Eur Respir J 2002; 20: Suppl. 38, 82s Year: 2002 Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Application of machine learning algorithms to predict loss of asthma control: A post-hoc analysis of INCONTRO study Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Statistical analysis of anthropometric differences between COPD stages 1 and 2 Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016